92765-79-2

Downstream Products

• 152457-10-8 N-Formyl-4-(tert-butyldimethylsiloxy)-2,6-xylidine 
• 142874-39-3 4-Formylamino-3,5-dimethyl-1-(2-methyl-2-propenyloxy)benzene 
• 152457-20-0 1-<1-<<4-(tert-Butyldimethylsiloxy)-2,6-xylyl>amino>-3-phenylpropyl>cyclohexanol 
• 152457-11-9 4-(tert-Butyldimethylsiloxy)-2,6-xylyl isocyanide 
• 142874-46-2 2,6-Bis(2-methyl-2-propenyl)-4-formylamino-3,5-dimethylphenol 
• 142874-40-6 N-[2,6-Dimethyl-3-(2-methyl-allyl)-4-(2-methyl-allyloxy)-phenyl]-formamide 
• 142874-45-1 N-[4-hydroxy-2,6-dimethyl-3-(2-methyl-2-propenyl)phenyl]formamide 

Relevant academic research and scientific papers

Aminocoumaran derivatives, their production and use

A novel aminocoumaran derivatives of the general formula (I): STR1 wherein R1 and R2 are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R3 R4 and R5 are an optionally acylated hydroxyl optionally substituted amino group, alkoxy group or aliphatic group, or two of R3, R4 and R5 may be linked together to form a carbocyclic group; R6 and R7 are an aliphatic group and at least one of them has a methylene group at the α-position; R8 and R9 are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for preventing and treating various diseases such as arterial schleosis, hepatopathy, cerebrovascular diseases and the like.